A therapy is a cure for health problems, which normally is administered after the diagnosis of the patient. The therapeutic equipments and services mainly cater to the home healthcare segment such as physical therapies or speech therapies. The sectio ....see more
The ventilators market is expected to grow from USD 1.4 billion in 2021 to USD 1.9 billion in 2026, at a compound annual growth rate (CAGR) of 7.6% during the forecast period.The Prominent players Koninklijke Philips N.V. (Netherlands), ResMed (US), Medtronic (Ireland), Fisher & Paykel Healthcare Limited (New Zealand), Drägerwerk AG & CO. KGAA (Germany), Nihon Kohden Corporation (Japan), Getinge AB (Sweden), Asahi Kasei Corporation (Japan), Air Liquide (France), Vyaire Medical, Inc. (US), GE Healthcare (US), Hamilton Medical (Switzerland), Smiths Group plc (UK) and Allied Healthcare Products, Inc. (US).
The global cold plasma market is expected to grow from USD 1.6 billion in 2021 to USD 3.3 billion by 2026, at a compound annual growth rate (CAGR) of 15.0% during the forecast period.The prominent players Apyx Medical Corporation (US), Nordson Corporation (US), Adtec Plasma Technology Co. Ltd. (Japan), P2i (UK), Relyon Plasma GmbH, (Germany), Henniker Plasma (UK), Enercon Industries (US), AcXys Plasma Technologies (France), Plasmatreat (Germany), Tantec A/S (Denmark), Europlasma (Belgium), Thierry Corporation (Germany), Surfx Technologies (US), SOFTAL Corona & Plasma (Germany), Coating Plasma Innovation (France), Ferrarini & Benelli (Italy), Neoplas GmbH (Germany), terraplasma GmbH (Germany), Molecular Plasma Group (Germany), and CINOGY GmbH (Germany), US Medical Innovation (US).
The Diabetes Care Devices Market is expected to grow from USD 1.7 billion in 2020 to USD 4.3 billion by 2025, at a CAGR of 16.2% during the forecast period. The prominent players in the diabetes care devices (BRIC) market include Medtronic plc (Ireland), B. Braun (Germany), DexCom, Inc. (US), Abbott (US), F. Hoffman-La Roche Ltd. (Switzerland), Ascensia Diabetes Care Holdings AS (Switzerland), LifeScan (US), AgaMatrix Holdings LLC (US), Acon Laboratories, Inc. (US), ARKRAY USA, Inc. (US), Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (US), Sanofi (France), Terumo Corporation (Japan), SD Biosensor, Inc. (South Korea), MicroGene Diagnostic Systems Pvt. Ltd. (India), Ypsomed Holdings AG (Switzerland), Dr. Morepen (India), Sinocare, Inc. (China), Bionime Corporation (Taiwan), and Rossmax International Ltd. (Taiwan).
The apheresis market is expected to grow from USD 1.7 billion in 2019 to USD 2.7 billion by 2025, at a compound annual growth rate (CAGR) of 8.1% during the forecast period.The key players in the global apheresis market are Terumo BCT, Inc. (US), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Cerus Corporation (US), Kaneka Corporation (Japan), Kawasumi Laboratories, Inc. (Japan), and Nikkiso Co., Ltd. (Japan).
The ophthalmic lasers market is projected to reach USD 1,245.4 Million by 2021 from USD 970.2 Million in 2016, at a CAGR of 5.1%. Increasing prevalence of ophthalmic disorders, rising prevalence of chronic disorders, rapid growth in geriatric population, and increasing regulatory approvals for ophthalmic lasers are expected to drive the growth of the ophthalmic lasers market.
The critical care equipment market for asia and north Africa is expected to reach $2.61 billion by 2021 from $1.78 billion in 2016, at a CAGR of 8.0% during the forecast period. Continuous technological advancements in critical care devices, increasing government support, growing private sector investments in the healthcare industry, and increasing patient population base are key factors fuelling the growth of the global market of critical care equipment in the emerging nations.
Global ophthalmology drug and devices market is witnessing a significant growth due to the increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration, and diabetic retinopathy among the aging population. With the introduction of ophthalmic devices equipped with sophisticated technologies, people are increasingly opting for ophthalmic surgeries to correct their eye related disorders.
This market report will enable strategic understanding on the ophthalmology devices & drugs market. Each section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass more than 40 company profiles.
Dental consumables form the largest segment of the dental industry, and also hold significant potential for further growth due to the increasing incidence of oral disease and growing awareness about oral care. The growth of the dental consumables market is also driven by the demand from the increasing population of aging people across the globe, as well as from the younger generation focusing on dental aesthetics.
The report provides market data on the latest and future equipment and technologies in the market. It also analyzes the key market trends, strategies of the key players and provides market data for the next five years. The focus is on the patented equipment and technologies being developed across the globe.